Akebia Therapeutics
Clinical trials sponsored by Akebia Therapeutics, explained in plain language.
-
New hope for FSGS: experimental drug enters Mid-Stage trial
Disease control Recruiting nowThis study tests an experimental drug called praliciguat in 60 adults with a rare kidney disease called FSGS. The goal is to see if it can reduce protein in the urine, a sign of kidney damage. Participants will first receive either the drug or a placebo for 24 weeks, then everyon…
Phase: PHASE2 • Sponsor: Akebia Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
New drug AKB-9090 takes first steps in human safety trial
Knowledge-focused Recruiting nowThis early-stage study is testing a new drug, AKB-9090, in about 70 healthy adults to see if it is safe and how the body processes it. Participants will receive either the drug or a placebo, given through a vein, in either a single dose or multiple doses over time. The main goal …
Phase: PHASE1 • Sponsor: Akebia Therapeutics • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:07 UTC